Browsing Tag
Olivier Laureau
3 posts
Servier bets $2.5bn on pediatric cancer specialist Day One Biopharmaceuticals (Nasdaq: DAWN)
Servier is acquiring Day One Biopharmaceuticals for $2.5B to expand its rare oncology pipeline. Discover what the deal means for pediatric cancer drug innovation.
Servier to acquire Danish antibody discovery company Symphogen
Servier acquisition of Symphogen : French pharma company Servier has agreed to acquire Danish antibody discovery company Symphogen,…
Servier Laboratories to acquire Shire’s oncology business for $2.4bn
In a strategic move to expand its global presence, French pharmaceutical giant Servier Laboratories has announced a $2.4…